Search research articles
Contact Us
Filters
Showing results (181-190 of 221) with videos related to
Page
of 23
Sort By:
Journal for Immunotherapy of Cancer
|
October 10, 2020
Avelumab as second-line therapy for metastatic, platinum-treated urothelial carcinoma in the phase Ib JAVELIN Solid Tumor study: 2-year updated efficacy and safety analysis
Andrea B Apolo, John A Ellerton, Jeffrey R Infante, et al.
Annals of the Rheumatic Diseases
|
November 18, 2017
Rheumatic disorders associated with immune checkpoint inhibitors in patients with cancer-clinical aspects and relationship with tumour response: a single-centre prospective cohort study
Marie Kostine, Léa Rouxel, Thomas Barnetche, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 25, 2013
Functional decline in older patients with cancer receiving first-line chemotherapy
Stéphanie Hoppe, Muriel Rainfray, Marianne Fonck, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 1, 2018
Sunitinib Prior to Planned Nephrectomy in Metastatic Renal Cell Carcinoma: Angiogenesis Biomarkers Predict Clinical Outcome in the Prospective Phase II PREINSUT Trial
Laetitia Mauge, Arnaud Mejean, Laure Fournier, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 17, 2017
A multicenter phase II study of sunitinib in patients with locally advanced or metastatic differentiated, anaplastic or medullary thyroid carcinomas: mature data from the THYSU study
Alain Ravaud, Christelle de la Fouchardière, Philippe Caron, et al.
Molecular Cancer
|
October 21, 2021
Experimental and computational modeling for signature and biomarker discovery of renal cell carcinoma progression
Lindsay S Cooley, Justine Rudewicz, Wilfried Souleyreau, et al.
European Urology Oncology
|
February 22, 2021
Toxicity and Surgical Complication Rates of Neoadjuvant Atezolizumab in Patients with Muscle-invasive Bladder Cancer Undergoing Radical Cystectomy: Updated Safety Results from the ABACUS Trial
Bernadett Szabados, Alejo Rodriguez-Vida, Ignacio Durán, et al.
European Urology
|
April 16, 2017
Treatment Beyond Progression in Patients with Advanced Renal Cell Carcinoma Treated with Nivolumab in CheckMate 025
Bernard Escudier, Robert J Motzer, Padmanee Sharma, et al.
European Urology
|
October 3, 2017
Adjuvant Sunitinib for High-risk Renal Cell Carcinoma After Nephrectomy: Subgroup Analyses and Updated Overall Survival Results
Robert J Motzer, Alain Ravaud, Jean-Jacques Patard, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 3, 2014
Multicentre randomised phase II trial of gemcitabine+platinum, with or without trastuzumab, in advanced or metastatic urothelial carcinoma overexpressing Her2
Stéphane Oudard, Stéphane Culine, Yann Vano, et al.
Page
of 23
Search research articles
Search
Showing results (181-190 of 221) with videos related to
Sort By:
Page
of 23
Journal for Immunotherapy of Cancer
|
October 10, 2020
Avelumab as second-line therapy for metastatic, platinum-treated urothelial carcinoma in the phase Ib JAVELIN Solid Tumor study: 2-year updated efficacy and safety analysis
Andrea B Apolo, John A Ellerton, Jeffrey R Infante, et al.
Annals of the Rheumatic Diseases
|
November 18, 2017
Rheumatic disorders associated with immune checkpoint inhibitors in patients with cancer-clinical aspects and relationship with tumour response: a single-centre prospective cohort study
Marie Kostine, Léa Rouxel, Thomas Barnetche, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 25, 2013
Functional decline in older patients with cancer receiving first-line chemotherapy
Stéphanie Hoppe, Muriel Rainfray, Marianne Fonck, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 1, 2018
Sunitinib Prior to Planned Nephrectomy in Metastatic Renal Cell Carcinoma: Angiogenesis Biomarkers Predict Clinical Outcome in the Prospective Phase II PREINSUT Trial
Laetitia Mauge, Arnaud Mejean, Laure Fournier, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 17, 2017
A multicenter phase II study of sunitinib in patients with locally advanced or metastatic differentiated, anaplastic or medullary thyroid carcinomas: mature data from the THYSU study
Alain Ravaud, Christelle de la Fouchardière, Philippe Caron, et al.
Molecular Cancer
|
October 21, 2021
Experimental and computational modeling for signature and biomarker discovery of renal cell carcinoma progression
Lindsay S Cooley, Justine Rudewicz, Wilfried Souleyreau, et al.
European Urology Oncology
|
February 22, 2021
Toxicity and Surgical Complication Rates of Neoadjuvant Atezolizumab in Patients with Muscle-invasive Bladder Cancer Undergoing Radical Cystectomy: Updated Safety Results from the ABACUS Trial
Bernadett Szabados, Alejo Rodriguez-Vida, Ignacio Durán, et al.
European Urology
|
April 16, 2017
Treatment Beyond Progression in Patients with Advanced Renal Cell Carcinoma Treated with Nivolumab in CheckMate 025
Bernard Escudier, Robert J Motzer, Padmanee Sharma, et al.
European Urology
|
October 3, 2017
Adjuvant Sunitinib for High-risk Renal Cell Carcinoma After Nephrectomy: Subgroup Analyses and Updated Overall Survival Results
Robert J Motzer, Alain Ravaud, Jean-Jacques Patard, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 3, 2014
Multicentre randomised phase II trial of gemcitabine+platinum, with or without trastuzumab, in advanced or metastatic urothelial carcinoma overexpressing Her2
Stéphane Oudard, Stéphane Culine, Yann Vano, et al.
Page
of 23